ZA965924B - Use of 1,4-dihydropyridine derivatives in the prevention and therapy of atherosclerotic degradation of arterial walls - Google Patents

Use of 1,4-dihydropyridine derivatives in the prevention and therapy of atherosclerotic degradation of arterial walls

Info

Publication number
ZA965924B
ZA965924B ZA965924A ZA965924A ZA965924B ZA 965924 B ZA965924 B ZA 965924B ZA 965924 A ZA965924 A ZA 965924A ZA 965924 A ZA965924 A ZA 965924A ZA 965924 B ZA965924 B ZA 965924B
Authority
ZA
South Africa
Prior art keywords
arterial walls
therapy
prevention
lercanidipine
atherosclerotic
Prior art date
Application number
ZA965924A
Other languages
English (en)
Inventor
Abraham Sartani
Amedeo Leonardi
Rodolfo Testa
Original Assignee
Recordati Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati Chem Pharm filed Critical Recordati Chem Pharm
Publication of ZA965924B publication Critical patent/ZA965924B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA965924A 1995-07-14 1996-07-12 Use of 1,4-dihydropyridine derivatives in the prevention and therapy of atherosclerotic degradation of arterial walls ZA965924B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI951513A IT1275532B (it) 1995-07-14 1995-07-14 Uso di derivati 1,4-diidropiridinici per la prevenzione e la terapia della degenerazione aterosclerotica della parete arteriosa

Publications (1)

Publication Number Publication Date
ZA965924B true ZA965924B (en) 1997-01-30

Family

ID=11371972

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA965924A ZA965924B (en) 1995-07-14 1996-07-12 Use of 1,4-dihydropyridine derivatives in the prevention and therapy of atherosclerotic degradation of arterial walls

Country Status (19)

Country Link
EP (1) EP0839036B1 (xx)
JP (1) JPH11509214A (xx)
KR (1) KR19990028741A (xx)
CN (1) CN1190345A (xx)
AT (1) ATE183644T1 (xx)
AU (1) AU690471B2 (xx)
CA (1) CA2219501A1 (xx)
CZ (1) CZ11698A3 (xx)
DE (1) DE69603968T2 (xx)
DK (1) DK0839036T3 (xx)
ES (1) ES2138359T3 (xx)
GR (1) GR3031096T3 (xx)
HU (1) HUP9802736A3 (xx)
IL (1) IL122302A (xx)
IT (1) IT1275532B (xx)
NO (1) NO980171L (xx)
SK (1) SK4198A3 (xx)
WO (1) WO1997003669A1 (xx)
ZA (1) ZA965924B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20011726A1 (it) * 2001-08-06 2003-02-06 Recordati Ind Chimica E Farma Forme polimorfe della lercanidipina cloridrato
US6852737B2 (en) 2001-08-06 2005-02-08 Recordati Ireland Limited Crude and crystalline forms of lercanidipine hydrochloride
TW200613275A (en) * 2004-08-24 2006-05-01 Recordati Ireland Ltd Lercanidipine salts
AR053023A1 (es) * 2005-02-25 2007-04-18 Recordati Ireland Ltd Base libre de lercanidipina, metodos para su preparacion y composiciones farmaceuticas que las contienen
WO2011161223A2 (en) 2010-06-23 2011-12-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Pharmaceutical oral dosage forms comprising lercanidipine and enalapril and their pharmaceutically acceptable salts
BR112013008601B1 (pt) 2010-10-12 2020-03-31 Chiesi Farmaceutici S.P.A. Formulações de emulsão de clevidipina contendo agentes antimicrobianos
US8658676B2 (en) 2010-10-12 2014-02-25 The Medicines Company Clevidipine emulsion formulations containing antimicrobial agents
EP2654729B1 (en) 2010-12-24 2016-05-04 KRKA, d.d., Novo mesto Homogenous pharmaceutical oral dosage forms comprising lercanidipine and enalapril or their pharmaceutically acceptable salts together with an organic acid

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8403866D0 (en) * 1984-02-14 1984-03-21 Recordati Chem Pharm Diphenylalkylaminoalkyl esters

Also Published As

Publication number Publication date
WO1997003669A1 (en) 1997-02-06
HUP9802736A3 (en) 2000-03-28
DE69603968T2 (de) 2000-04-06
ITMI951513A0 (it) 1995-07-14
DK0839036T3 (da) 2000-01-24
EP0839036B1 (en) 1999-08-25
CN1190345A (zh) 1998-08-12
GR3031096T3 (en) 1999-12-31
ITMI951513A1 (it) 1997-01-14
NO980171D0 (no) 1998-01-14
IT1275532B (it) 1997-08-07
IL122302A0 (en) 1998-04-05
CZ11698A3 (cs) 1998-06-17
JPH11509214A (ja) 1999-08-17
ATE183644T1 (de) 1999-09-15
AU690471B2 (en) 1998-04-23
KR19990028741A (ko) 1999-04-15
EP0839036A1 (en) 1998-05-06
ES2138359T3 (es) 2000-01-01
CA2219501A1 (en) 1997-02-06
AU6516496A (en) 1997-02-18
DE69603968D1 (de) 1999-09-30
HUP9802736A2 (hu) 1999-03-29
NO980171L (no) 1998-01-14
SK4198A3 (en) 1998-05-06
IL122302A (en) 2000-08-13

Similar Documents

Publication Publication Date Title
HUP9603530A3 (en) Process for producing pharmaceutical compositions containing agent in polymer-matrix and in solid solution form and these medicaments
NO975985L (no) Aromatiske forbindelser og farmasöytiske blandinger inneholdende dem
AU7053494A (en) Method of treating coronary vascular disease using docosahexaenoic acid
HU9401411D0 (en) Bile acid derivatives, process for producing them and pharmaceutical compositions containing them
AU2995892A (en) Physiological tear compositions and methods for their preparation
IL102571A0 (en) Pharmaceutical composition for the treatment of heart failure containing an inhibitor of neutral endopeptidase
KR987000336A (en) Amphiphilic complexes, method for their preparation and compositions containing them
AU4254696A (en) Novel substituted dtpa derivatives, their metal complexes, pharmaceutical compositions containing these complexes and their use in diagnosis and therapy
NO975984L (no) Aromatiske forbindelser og farmasöytiske blandinger inneholdende dem
AU6914296A (en) Left coronary artery catheter
GR3031096T3 (en) Use of 1,4-dihydropyridine derivatives in the prevention and therapy of atherosclerotic degradation of arterial walls
NZ303200A (en) Substituted 1h-indole-2-carboxylic acid derivatives and medicaments
ATA900894A (de) Pharmazeutische kompositionen zum vorbeugen und heilen von krebserkrankungen und verfahren zu ihrer herstellung
HUT51268A (en) Process for producing isoindoline derivatives and pharmaceutical compositions comprising same
IL121217A0 (en) Pharmaceutical composition for treating chronic progressive vascular diseases
UA35566C2 (uk) Лікарський засіб для профілактики і лікування порушень ліпоїдного і холестеринового обміну речовин і спосіб профілактики і лікування цих порушень
TW372962B (en) Pharmaceutical compositions for the prevention, arrest or reversal of atherosclerotic degradation in the arterial walls of a patient
AU3300789A (en) Floor treatment product
PL301653A1 (en) Pharmaceutical agent for preventing or treating arteriosclerosis
AU8058194A (en) A pharmaceutical composition for the treatment of coronary thrombosis
AU3011295A (en) Use of 1,4-dihydropyridine-3,5-dicarboxylic acid esters as medicaments
AU7389496A (en) Methods and compositions for treating vascular stenosis
AU2899099A (en) Composition for treatment and prevention of coronary artery disease
AU2575895A (en) Pharmaceutical composition for treating chronic arterial occlusion
EP0720608A1 (de) Neue bishispidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel